SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-17-003270
Filing Date
2017-10-11
Accepted
2017-10-11 07:40:55
Documents
9
Period of Report
2017-10-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e617372_8k-adma.htm 8-K 39432
2 e617372_ex4-1.htm EX-4.1 11186
3 e617372_ex4-2.htm EX-4.2 75723
4 e617372_ex10-1.htm EX-10.1 531651
5 e617372_ex10-2.htm EX-10.2 144984
6 e617372_ex10-3.htm EX-10.3 47235
7 e617372_ex10-4.htm EX-10.4 75756
8 e617372_ex99-1.htm EX-99.1 18612
9 GRAPHIC logo.jpg GRAPHIC 11097
  Complete submission text file 0001193805-17-003270.txt   961551
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 171131758
SIC: 2836 Biological Products, (No Diagnostic Substances)